Browser-side verification
Verify Phenoxybenzamine
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "phenoxybenzamine",
"nameEn": "Phenoxybenzamine",
"nameTh": "ฟีนอกซีเบนซามีน",
"class": "Urinary — alpha-adrenergic antagonist (urethral relaxant)",
"mechanism": "irreversible non-selective alpha-adrenergic blocker — คลายกล้ามเนื้อเรียบของหูรูดท่อปัสสาวะส่วนใน (internal urethral sphincter) และขยายหลอดเลือด; ออกฤทธิ์ยาว (จับ receptor ถาวร)",
"brandNamesTh": [
"Dibenzyline"
],
"indications": [
{
"text": "คลายหูรูดท่อปัสสาวะใน functional urethral obstruction / reflex dyssynergia (internal sphincter tone สูง) ในสุนัขและแมว; เตรียมก่อนผ่าตัด pheochromocytoma (คุมความดัน)",
"cites": [
"merck-urine-retention-b",
"petplace-phenoxybenzamine"
]
}
],
"contraindications": [
{
"text": "ออกฤทธิ์ช้า (อาจ 3–5 วันกว่าเห็นผลเต็มที่ — irreversible binding); ⚠️ hypotension + reflex tachycardia + คัดจมูก; ระวังในโรคหัวใจ/ไตวาย; titrate จากขนาดต่ำ",
"cites": [
"merck-urine-retention-b",
"petplace-phenoxybenzamine"
]
}
],
"sideEffects": [
{
"text": "ความดันต่ำ หัวใจเต้นเร็วสะท้อนกลับ อ่อนแรง เวียน คัดจมูก; ออกฤทธิ์นานหลังหยุดยา",
"cites": [
"petplace-phenoxybenzamine"
]
}
],
"dosages": [
{
"species": "canine",
"indication": "Reflex dyssynergia / urethral relaxation",
"route": "PO",
"dose": "0.25–1 mg/kg PO ทุก 8–24 ชั่วโมง อย่างน้อย 5 วัน (หรือ 5–20 mg/ตัว วันละ 1–2 ครั้ง)",
"cites": [
"merck-urine-retention-b",
"petplace-phenoxybenzamine"
]
},
{
"species": "feline",
"indication": "Functional urethral obstruction",
"route": "PO",
"dose": "2.5–7.5 mg/ตัว PO วันละ 1–2 ครั้ง",
"cites": [
"petplace-phenoxybenzamine"
]
}
],
"citations": [
{
"id": "merck-urine-retention-b",
"type": "textbook",
"title": "Pharmacotherapeutics in Urine Retention in Animals — MSD/Merck Veterinary Manual",
"year": 2025,
"url": "https://www.merckvetmanual.com/pharmacology/systemic-pharmacotherapeutics-of-the-urinary-system/pharmacotherapeutics-in-urine-retention-in-animals",
"note": "Authoritative veterinary pharmacology reference. Copyrighted, cited not mirrored.",
"cid": null
},
{
"id": "petplace-phenoxybenzamine",
"type": "monograph",
"title": "Phenoxybenzamine (Dibenzyline) for Dogs and Cats — PetPlace",
"url": "https://www.petplace.com/article/drug-library/drug-library/library/phenoxybenzamine-dibenzyline-for-dogs-and-cats",
"year": 2025,
"note": "Clinical veterinary drug reference.",
"cid": null
},
{
"id": "wikipedia-phenoxybenzamine",
"type": "monograph",
"title": "Phenoxybenzamine — Wikipedia",
"year": 2026,
"url": "https://en.wikipedia.org/wiki/Phenoxybenzamine",
"note": "Tertiary cross-check for class + mechanism. CC BY-SA 4.0. Not sole authority.",
"cid": null
}
],
"mirroredFrom": [
{
"id": "who-atc",
"name": "WHO ATC/DDD Index",
"url": "https://www.whocc.no/atc_ddd_index/",
"asOfDate": "2026-05-31",
"license": "WHO publication, free for use with attribution"
}
],
"mirrorCIDs": [],
"codes": {
"atc": {
"code": "C04AX02",
"name": "Phenoxybenzamine",
"level": 5
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-31",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-31",
"version": 1,
"changelog": [
{
"version": 1,
"date": "2026-05-31",
"summary": "New entry — clinical content compiled from cited authoritative sources (Merck Veterinary Manual / FDA-EMA labels / VIN / peer-reviewed), cross-checked. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
]
}Public keys used
[]